Lilly Buys AtaiBeckley, Wonder Raises $650M, AI Decodes the Brain
July 17, 2026: Your daily rundown of health and wellness news, in under 5 minutes.
Today's top stories:
Eli Lilly acquires AtaiBeckley for up to $3.8B, the largest psychedelic medicine deal yet, gaining an intranasal DMT therapy in Phase 3 for depression
Wonder closes $650M Series D at $9B valuation, building a vertically integrated food platform spanning restaurants, delivery, and AI personalization
Hemispheric emerges from stealth with $52M and Descartes, a foundation AI model trained on EEG data to diagnose depression, PTSD, and Alzheimer's
Today's episode is brought to you by AIIR — a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.